BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23731084)

  • 1. Reducible hyaluronic acid-siRNA conjugate for target specific gene silencing.
    Park K; Yang JA; Lee MY; Lee H; Hahn SK
    Bioconjug Chem; 2013 Jul; 24(7):1201-9. PubMed ID: 23731084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
    ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
    Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
    Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
    Jiang G; Park K; Kim J; Kim KS; Hahn SK
    Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
    Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
    Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery.
    Jang YL; Ku SH; Jin S; Park JH; Kim WJ; Kwon IC; Kim SH; Jeong JH
    J Nanosci Nanotechnol; 2014 Oct; 14(10):7388-94. PubMed ID: 25942799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing.
    Chung HJ; Hong CA; Lee SH; Jo SD; Park TG
    Bioconjug Chem; 2011 Feb; 22(2):299-306. PubMed ID: 21222435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled siRNA-PLGA conjugate micelles for gene silencing.
    Lee SH; Mok H; Lee Y; Park TG
    J Control Release; 2011 May; 152(1):152-8. PubMed ID: 21185893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
    Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
    Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional triblock co-polymer mP3/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing.
    Zhou L; Chen Z; Wang F; Yang X; Zhang B
    Acta Biomater; 2013 Apr; 9(4):6019-31. PubMed ID: 23295402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copolymer of poly(ethylene glycol) and poly(L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery.
    Li J; Cheng D; Yin T; Chen W; Lin Y; Chen J; Li R; Shuai X
    Nanoscale; 2014; 6(3):1732-40. PubMed ID: 24346086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM; Jang M; Kim JH; Ahn HJ
    Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
    Mok H; Park JW; Park TG
    Bioconjug Chem; 2007; 18(5):1483-9. PubMed ID: 17602578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
    Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
    J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid.
    Chen CJ; Zhao ZX; Wang JC; Zhao EY; Gao LY; Zhou SF; Liu XY; Lu WL; Zhang Q
    Int J Nanomedicine; 2012; 7():3837-49. PubMed ID: 22888238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
    Lee H; Mok H; Lee S; Oh YK; Park TG
    J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
    Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
    J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
    Nascimento TL; Hillaireau H; Noiray M; Bourgaux C; Arpicco S; Pehau-Arnaudet G; Taverna M; Cosco D; Tsapis N; Fattal E
    Langmuir; 2015 Oct; 31(41):11186-94. PubMed ID: 26375384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.